To utilize the Surveillance, Epidemiology, and End Results (SEER) registry to examine trends in grade assignment. Data from 411 325 patients from 1984 to 2003 were analyzed for grade migration and for cause-specific survival (CSS) as a function of grade. There has been a significant grade migration during the study period (Po0.001), principally from well-differentiated (WD) to moderately differentiated (MD) disease. Five-year CSS of MD and WD patients have converged, suggesting a decreasing role of grade as a prognostic factor. A grade migration from WD to MD assignment has occurred, suggesting that prognostic categorizations based on grade across eras may be difficult to interpret.
Introduction
Prostate cancer is the most common solid malignancy diagnosed, due in part to widespread rectal exam and prostate-specific antigen (PSA)-based screening.
1,2 The impact of PSA screening has been studied for its role in reducing cause-specific mortality. There appears to have been a decrease in mortality over the PSA era, but the multifactorial nature of this decrease makes the impact of PSA screening difficult to interpret. 3 Furthermore, screening has been shown to cause first an increase followed by a decrease in prostate cancer incidence; this phenomenon is known as the cull effect. 4 In addition to an increase in incidence, the cull effect may be expected to cause a rise in diagnosis intermediate-and high-grade disease (over low-grade disease) due to disease latency in the previously unscreened cohort.
Many of the landmark studies evaluating the impact of PSA screening were done using the Surveillance, Epidemiology, and End Results (SEER) database. 5 This database consists of registries across the United States, and represents a major resource for investigators wishing to study the natural history and treatment strategies for prostate cancer. In addition to the early studies looking at the impact of PSA screening on mortality of prostate cancer, SEER data have been used to evaluate the impact of PSA screening on the diagnosis of prostate cancer. 5 One concern at the onset of PSA-based screening was the detection of clinically insignificant prostate cancer. Although still an area of controversy, many of these concerns were alleviated by a series of studies done in the late 1990s examining the grade of prostate cancers diagnosed. PSA screening was found to be associated with an initial surge in the incidence of prostate cancer; however, much of this surge was an increase in moderately differentiated (MD), not well-differentiated (WD) prostate cancer. [6] [7] [8] Others have looked at chronological, interpretative and translation biases related to the SEER grade categorization. 9 The issue of grade migration is an important one; the motivation for the above studies is that grade is a critical factor used to determine patient treatment. Grade is a key factor used in many prostate cancer decisions. Grade assignment may affect whether prostate cancer can be safely observed, 10 the role of androgen ablation, 11 the choice between surgery and radiotherapy, 1 the need for post-prostatectomy radiotherapy, 12 whether to offer brachytherapy 1 and whether to use supplemental external beam radiotherapy with brachytherapy. 13 Thus, it is critical to understand the trends of prostate cancer grade during the PSA era. Although grade migration has been studied in single-institution and regional registry settings, the national SEER database has not been queried over the past decade to determine whether grade migration has occurred since the start of widespread PSA screening. This is the goal of the current investigation.
Methods
The public-access SEER data The study period was divided into 5-year intervals, with the reference interval being 1984-1988 (the period just before PSA screening was undertaken), and three subsequent 5-year intervals since (1989-1993, 1993-1998 and 1999-2003) . Three time-trend queries were raised: (1) grade by interval, (2) stage by interval, (3) grade by stage and by interval. The intent of query (1) was to determine if a grade migration (defined as a change in the relative percentage of WD, MD and PD diseases) has occurred. The intent of query (2) was to determine whether a stage migration (defined as a change in the relative percentage of stage 0/1, stage 2 and stage 3 diseases) has occurred. The intent of query (3) was to determine if there was a grade migration within each stage subgroup. Statistical analyses were performed using the two-dimensional w 2 test. 16 Five-year cause-specific survivals (CSSs) were computed and plotted by year of diagnosis for each category of grade (WD, MD and PD), in an effort to determine qualitatively if grade has maintained its role as a prognostic factor through the study period. Two additional queries were raised: (4) age by year and (5) grade by year. These queries were done to understand qualitatively if any observed grade patterns were due to changes in demographics of the study population. (2) (stage by year). As shown, stage has also drifted, though not as dramatically (P ¼ 0.025) and in a different direction (shift from stage 2 to stage 0/1 in recent years) as the grade migration. Table 1 (c) shows the results of query (3) (grade by stage and by year). As shown, the shift from WD to MD disease occurred for all three stage groupings. The migration was particularly strong for the stage 0/1 (Po0.001) and stage 2 (Po0.001) groupings (in which WD disease only comprised o1 and 2% of all disease, respectively for the 1999-2003 interval), and was less prominent within the stage 3 grouping (P ¼ 0.07), presumably because WD disease was uncommon in this stage from the start of the study period (11% in the 1984-1988 interval, compared with 40 and 32% for stage 0/1 and stage 2 diseases, respectively, for this same interval). Table 1 (d) shows the results of the age analysis during the study period; as shown, no significant change has taken place. Table 1 (e) shows the results of the race analysis during the study period. Although there has been a shift from the 'Caucasian' to 'Other' categories (perhaps due to definitional reclassifications during the study period), overall there was no race trend observed. Tables 1(d) and (e) suggest that demographic factors are generally stable over the study period and are not likely to be the reason for the observed grade migration. Figure 1 shows the 5-year CSS by calendar year as a function of grade. As shown, the CSS of patients diagnosed with WD and MD diseases have come much closer together in recent years, whereas CSS of patients diagnosed with PD disease remained lower throughout the study period. This retention of PD as a prognostic factor is consistent with the stable to slightly increasing percentage of PD disease over time in virtually all categories in Table 1 (a-c).
Results

Discussion
Since the early SEER analyses were done, [5] [6] [7] [8] [9] no one has updated these analyses to determine whether the surge in the increase of MD disease was due to the cull effect or whether it was a systematic trend over the PSA era. Single-institution studies have been undertaken, documenting that a grade migration has taken place. Some studies have examined upgrading by pathologists [17] [18] whereas others have examined stage migration with a decrease in extracapsular extension documented on prostatectomy specimens. [19] [20] [21] [22] [23] Grading inconsistencies have been examined in the context of extended biopsy 24 and in the context of influencing radiotherapy decisions. 25 A recent regional database analysis of the Connecticut Tumor Registry documented a grade migration, with a demonstrated decline in the incidence of low-grade disease when reread by experienced pathologists blinded to the original classification. 26 Additionally, an analysis using the CaPSURE database revealed a shift from low-to intermediate-grade disease. 27 Our study demonstrates that a significant grade migration has occurred from the period just before the widespread of PSA screening (1984) (1985) (1986) (1987) (1988) (1989) (1990) (1991) (1992) (1993) (1994) (1995) (1996) (1997) (1998) (1999) (2000) (2001) (2002) (2003) to more recent periods. While several single-institution and regional database analyses have explored this phenomenon, [17] [18] [19] [20] [21] [22] [23] [24] [25] ours is the largest such analysis in the PSA era using a national public-access database. The results indicate that grade migration has occurred across all stages of nonmetastatic disease and confirms that the most significant grade migration has occurred in early-stage disease. The results also indicate that the prognostic significance between WD and MD diseases is diminishing, as the CSS curves appear to be converging, as shown in Figure 1 . As shown, all three curves in this figure are slowly increasing, likely due to several factors, including improvements in treatment, lead-time bias and shorter follow-up in the most recently-diagnosed patients. Examination of PD patients has been examined recently; 28 in our study, we found that CSS has improved in recent years even in the PD patients, perhaps due to Grade migration in prostate cancer AB Jani et al the use of hormone therapy not captured by the SEER registry. However, despite these increased survival, assignment of grade to PD retains prognostic significance, as the PD curve does not appear to be converging with the WD and MD curves. From Figure 1 , MD and WD lesions in recent years have almost the same prognostic significance. Although there may be alternative explanations for this finding which cannot be captured or analyzed using the SEER database (for instance, due to PSA in the WD group increasing with time and causing patients in this group to behave as though they had MD disease), we believe that the most likely explanation is that many WD patients in past years are being read as MD. Thus, rather than due to any change in tumor biology, we feel the results can almost entirely be explained by changes in pathologic interpretation.
Our findings are consistent with recently described changes in pathology grading practices, notably pathology consensus statements related to a decreased ability to read low Gleason score disease on needle biopsy (and consequently raising the minimum Gleason sum read on needle biopsy). 26, 27 This change in pathologic criteria may improve pathologic reproducibility in diagnosis, but also caution the clinicians who rely critically on assigned grade for clinical decision making and for correlative comparisons across treatment periods.
Our study is not without its limitations, primarily due to the nature of the SEER data itself. One limitation of the SEER data, as described above, is that PSA is not available; indeed, though we considered a regression of variables for the CSS curves shown in Figure 1 , this lack of availability of PSA would make any such regression results difficult to interpret. If PSA were available, we would expect a slow decrease, as shown by analysis of the CaPSURE database. 25 An additional limitation is that Gleason grade cannot be analyzed on the original scale from 2 to 10, as the SEER system (WD, MD, PD) collapses Gleason grade into three instead of nine categories. This, however, is not a major limitation to our findings as such a grouping would likely have been done before analysis, and if anything, such a grouping underestimates the grade migration. 9 The grade migration within the MD category -specifically the migration from Gleason scores 5 to 6, or from Gleason scores 6 to 7, or from Gleason scores 3 þ 4 to 4 þ 3 -cannot be analyzed using SEER data. What can be established, though, is that very few tumors are being diagnosed as Gleason scores 2 through Grade migration in prostate cancer AB Jani et al 4 in recent years. Another important limitation of the SEER database is that the grade assigned is the highest recorded (that is, independent of type of specimenbiopsy vs prostatectomy), making the component of the observed grade migration attributable to changes in treatment modality (radiation vs surgery) difficult to interpret.
As discussed in the Introduction, other studies have explored the issue of grade migration. However, our study is notably different in that it (a) looks at grade migration within separate stage subgroups, (b) spans the largest period (1984) (1985) (1986) (1987) (1988) (1989) (1990) (1991) (1992) (1993) (1994) (1995) (1996) (1997) (1998) (1999) (2000) (2001) (2002) (2003) immediately before and since PSA screening and (c) explores the impact of grade assignment on CSS as a function of diagnosis year. Our study was conducted with the premise that once the initial/cull effect period had ended, PSA screening may result in an increase in the percentage of WD tumors due to the finding of disease earlier in its natural history. However, the decreasing percentage of WD disease and resultant shift to MD disease in our study suggests that trends in grade interpretation seem to be overriding the long-term increase in WD disease expected from screening efforts. The observation that the stage and grade migrations are in different directions in our study further bolsters this suggestion.
The results of our study have implications for interpretation of both past and future studies in prostate cancer. Although many of the three-tiered prognostic categorizations are based in part on grade (as well as PSA and T-stage), in these schema Gleason score p6 is considered favorable. If indeed many patients with Gleason score p6 disease in the past are being read as Gleason score 7 today, the prognostic categorization may need to be updated accordingly, as many clinical decisions, particularly with regard to selection of patients for radiotherapy, radiotherapy modality used and radiation dose used are based on grade. 1, 29 Our results also suggest that a modification of Gleason grading system corrected by year or era of diagnosis may be necessary.
Another important implication lies in the interpretation of outcome studies reported on the basis of grade. Researchers routinely compare treatment results between two sets of patients, whether it is comparison between two different treatment modalities or improvements in outcome with a single modality over time. With this in mind, patients having treatment more recently will demonstrate improved outcomes simply due to grade inflation owing to many of the WD patients being put into the MD category. Thus, the grade migration may artificially improve CSS for all prognostic categories due to the Will Rogers effect. 30 Although the degree to which interpretation of outcome studies is limited as this phenomenon needs to be explored further, it is clear from our study that a nation-wide grade migration from WD to MD assignment has occurred during the PSA era. This grade migration has slowly reduced the prognostic significance of MD disease and renders prognostic categorizations based on grade across eras difficult to interpret.
Conclusion
Although other studies have looked at grade migration, ours is the first using the national SEER registry to examine grade simultaneously as a function of stage, age and race and to examine CSS trends by grade. Our 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 Year of Diagnosis 5-year Cause-specific Survival Figure 1 Five-year cause-specific survival (CSS) by year of diagnosis for well-differentiated (WD) (solid line), moderately differentiated (MD) (dashed line), and poorly differentiated (PD) (dotted line) prostate cancer.
Grade migration in prostate cancer AB Jani et al results show that a grade migration from WD to MD assignment has occurred, suggesting that prognostic categorizations based on grade across eras may be difficult to interpret.
